Hosted on Acast. See acast.com/privacy for more information.

Hadas Alterman is an attorney who co-founded Plant Medicine Law Group, the first psychedelic industry focused law firm. She helped shape the legal psychedelic frameworks in Colorado and Oregon and the professional standards for psychedelic-assisted therapy. She is also working as a the director of legislative strategy for Stand With Us. Our topic today is how we can tolerate and accept very different world views in a conversations. In these times, this seems to be the number one talent we need to come up with human being. So how can psychedelic journeys contribute to this and have us tolerate messy conversations and understand the other camp? 

Linkedin:https://www.linkedin.com/in/hadasalterman/

Hosted on Acast. See acast.com/privacy for more information.

Dr. Leor Roseman, Senior Lecturer and Psychedelic Researcher at the University of Exeter, has explore this avenue. His study “Relational Processes in Ayahuasca Groups of Palestinians and Israelis” a few years ago, was fascinating.I read about it in 2021, (https://pmc.ncbi.nlm.nih.gov/articles/PMC8170481/) and we recorded the first podcast. To me the idea made a lot of sense. Now, with the urgency amid the current situation after October 7th, his work seems more important than ever. In his scientific work Leor examines how psychedelics can serve as peacemaking tools by altering consciousness through a biopsychosocial lens, incorporating neuroscience, psychology, anthropology, and phenom enology. With a background at the Centre for Psychedelic Research at Imperial College London, under Prof. Robin Carhart-Harris and Prof. David Nutt, Leor was curious how psychedelics now can deliver a new peacemaking tool. His foundation Ripples, a non-profit dedicated to peace building supported by psychedelics, is now researching new ideas around understanding, without ignoring the actual conflict. The urgency right now is on the Israel and Palestine Conflict. But his work can be valid for other conflicted parties too.  

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Today’s episode is particularly special. I recorded this session in our hotel room studio during the Psychedelic Science Conference in Denver. The duo you’ll hear shortly is truly exceptional in their efforts to destigmatize psychedelics, a movement gaining significant momentum right now.

My guests are Professor Rachel Yehuda and Governor Rick Perry. Professor Rachel Yehuda is the Director of the Parsons Research Center for Psychedelic Healing at the Icahn School of Medicine at Mount Sinai in New York City. She plays a pivotal role in pioneering psychedelic research related to veterans and PTSD.

Governor Rick Perry is a prominent American politician and the former governor of Texas. He also served as the 14th U.S. Secretary of Energy from 2017 to 2019. Perry has argued that ibogaine could be an incredible treatment for addiction and PTSD in veterans and has dedicated himself to advancing the public understanding and acceptance of psychedelics. In this episode, we discuss the evolving landscape of psychedelics in the United States, exploring why a bipartisan approach could be a powerful solution for rescheduling psychedelics and expanding access to healing therapies nationwide.

IG @rachelyehudaphd @secretaryperry https://www.nga.org/governor/rick-perry/ https://labs.icahn.mssm.edu/yehudalab/yehuda-team/

Hosted on Acast. See acast.com/privacy for more information.

This is a special episode I recorded in collaboration with Joe Moore from Psychedelics Today at the largest conference in the field "Psychedelic Science 2025" in Denver last week. It very early in the morning, at 8am, and it was fabulous. Our guests: Daniel Goldberg Co-Founder and Partner at Palo Santo & Bridge Investments & Zac Kamenetz, Founder of Shefa: Jewish Psychedelic Support, Joe and me were talking about the interactions of psychedelic community, the new role of Venture Capital in 2025 and what psychedelic systems are built in the current climate to support individuals and the bigger picture. Check out this episode, it's fun and very insightful.

Check out:

https://www.shefaflow.org/

https://palosanto.vc/

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Episode Highlights:

1. Introduction to the Situation in Europe:

• Overview of Europe's stance on psychedelics and its progress in psychedelic therapies.
• Historical context: France was the first to prohibit psychotropic substances ahead of the U.S. in the 1960s.

1. Current Research and Stigma Issues:

• Czech Republic as a pioneer in continued psychedelic research amidst widespread European prohibition.
• Switzerland's advancements since 2014 in psychedelic therapies for certain conditions.

1. Organizational Efforts and Personal Motivation:

• Discussion on initiating a European movement to integrate psychedelic therapies.
• Founder’s background from Strasbourg and motivation for creating the initiative.

1. Challenges in Promoting Psychedelics in the EU:

• The struggle of integrating a cohesive plan across diverse cultural and political landscapes in Europe.
• Advocacy through European Citizen Initiative to push legislative changes.

1. Strategic Goals and Legislative Pathway:

• Campaign to collect 1 million signatures to obligate EU action on psychedelic policies.
• Goals include establishing common standards for psychedelic care and boosting EU-funded research.

1. Mental Health Crisis and Economic Considerations:

• Addressing Europe's mental health and economic burdens through psychedelic therapies.
• The disparity between European initiatives and more advanced legislation in the US and Australia.

1. Public Engagement and Advocacy:

• Engaging content creators, influencers, and medical professionals in the conversation.
• Efforts to destigmatize psychedelics by raising public awareness.

1. Impact of Cultural and Political Differences:

• Addressing the unique cultural and political challenges within different European countries.
• Adapting strategies to fit local narratives and cultural sensitivities.

1. Looking Ahead:

• Potential benefits and implementation pathways for psychedelic therapies in Europe.
• The need for collaboration and knowledge-sharing among EU member states to advance policies and public understanding.

Call to Action:

• Encouragement for listeners to support the European initiative by signing petitions and spreading awareness.
• Suggestions for engaging in community discussions and using social media platforms to advocate for change.

Conclusion:

• Emphasize the importance of unified efforts to address mental health crises in Europe through innovative therapies.
• Listeners are encouraged to stay informed and take action to support the movement for psychedelic-assisted therapies.

Additional Resources:

• Follow the New Health Club podcast for further discussions on psychedelic therapies.
• and check out https://www.psychedelicare.eu/

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.